Atualização Científica >> Destaques da Produção Nacional


Hepatic steatosis, obesity, and the metabolic syndrome are independently and additively associated with increased systemic inflammation.

Ndumele CE, Nasir K, Conceiçao RD, Carvalho JA, Blumenthal RS, Santos RD. Arterioscler Thromb Vasc Biol. 2011 Aug;31(8):1927-32.

The Role of Soluble Fiber Intake in Patients under Highly Effective Lipid-lowering Therapy.

Ramos SC, Fonseca FA, Kasmas SH, Moreira FT, Helfenstein T, Borges NC, Moreno RA, Rezende VM, Silva FC, Izar MC. Nutr J. 2011 Aug 2;10(1):80. [Epub ahead of print].

The relationship between body mass index and the variation in plasma levels of triglycerides after short-term red wine consumption.

Cesena FH, Coimbra SR, Andrade AC, da Luz PL. J Clin Lipidol. 2011 Jul-Aug;5(4):294-8.

An artificial nanoemulsion carrying paclitaxel decreases the transplant heart vascular disease: a study in a rabbit graft model.

Lourenço-Filho DD, Maranhão RC, Méndez-Contreras CA, Tavares ER, Freitas FR, Stolf NA. J Thorac Cardiovasc Surg. 2011 Jun;141(6):1522-8.

Clinical perspective: have the results of recent clinical trials of lipid-lowering therapies influenced the way we should practice? A Latin American perspective of current issues in clinical lipidology.

Santos RD, Lorenzatti AJ, Barros CF, Escobar E; discussants from a Clinical Lipidology Roundtable of Latin American Physicians. J Clin Lipidol. 2011 May-Jun;5(3):124-32.

Timing and dose of statin therapy define its impact on inflammatory and endothelial responses during myocardial infarction.

Sposito AC, Santos SN, de Faria EC, Abdalla DS, da Silva LP, Soares AA, Japiassú AV, Quinaglia e Silva JC, Ramires JA, Coelho OR. Arterioscler Thromb Vasc Biol. 2011 May;31(5):1240-6.

Electronegative low-density lipoprotein: origin and impact on health and disease.

Mello AP, da Silva IT, Abdalla DS, Damasceno NR. Atherosclerosis. 2011 Apr;215(2):257-65.

Effect of exercise training on plasma levels and functional properties of high-density lipoprotein cholesterol in the metabolic syndrome.

Casella-Filho A, Chagas AC, Maranhão RC, Trombetta IC, Cesena FH, Silva VM, Tanus-Santos JE, Negrão CE, da Luz PL. Am J Cardiol. 2011 Apr 15;107(8):1168-72.

Pleiotropic effects of ezetimibe/simvastatin vs. high dose simvastatin.

Pesaro AE, Serrano CV Jr, Fernandes JL, Cavalcanti AB, Campos AH, Martins HS, Maranhão RC, de Lemos JA, Souza HP, Nicolau JC. Int J Cardiol. 2011 Feb 18. [Epub ahead of print].

[HDL: the yin-yang of cardiovascular disease]

Leança CC, Passarelli M, Nakandakare ER, Quintão EC. Arq Bras Endocrinol Metabol. 2010 Dec;54(9):777-84.

HDL-C concentration is related to markers of absorption and of cholesterol synthesis: Study in subjects with low vs. high HDL-C.

Nunes VS, Leança CC, Panzoldo NB, Parra E, Cazita PM, Nakandakare ER, de Faria EC, Quintão EC.Clin Chim Acta. 2011 Jan 14;412(1-2):176-80.

Lipid goals among patients with diabetes or metabolic syndrome: Lipid Treatment Assessment Project (L-TAP) 2.

Jukema JW, Chiang CW, Ferrières J, Santos RD, Verdejo J, Waters DD, et al. Curr Med Res Opin. 2010 Nov;26(11):2589-97.

Algorithm for the treatment of type 2 diabetes: a position statement of Brazilian Diabetes Society.

Lerario AC, Chacra AR, Pimazoni-Netto A, Malerbi D, Gross JL, Oliveira JE, Gomes MB, Santos RD, Fonseca RM, Betti R, Raduan R. Diabetol Metab Syndr. 2010 Jun 8;2(1):35.

Impact of high cholesterol intake on tissue cholesterol content and lipid transfers to high-density lipoprotein.

Oliveira TV, Maniero F, Santos MH, Bydlowski SP, Maranhão RC. Nutrition. 2010 Oct 8. [Epub ahead of print]

Exercise training accelerates the removal from plasma of LDL-like nanoemulsion in moderately hypercholesterolemic subjects.

Ficker ES, Maranhão RC, Chacra AP, Neves VC, Negrão CE, Martins VC, Vinagre CG. Atherosclerosis. 2010 Sep;212(1):230-6.

Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.

Hueb W, Lopes N, Gersh BJ, Soares PR, Ribeiro EE, Pereira AC, Favarato D, Rocha AS, Hueb AC, Ramires JA. Circulation. 2010 Sep 7;122(10):949-57.

The impact of obstructive slepp apnea on metabolic and inflammatory markers in consecutive patients with metabolic syndrome.

Drager LF, Lopes HF, Maki-Nunes C, Trombetta IC, Toschi-Dias E, Alves MJ, Fraga RF, Jun JC, Negrão CE, Krieger EM, Polotsky VY, Lorenzi-Filho G. PLoS One. 2010 Aug 11;5(8). pii: e12065.

Atherosclerosis in obstructive sleep apnoea: it does not matter whether patients are sleepy or not.

Drager LF, Bortolotto LA, Maki-Nunes C, Trombetta IC, Negrão CE, Krieger EM, Lorenzi-Filho G. Atherosclerosis. 2010 Jul;211(1):30-1.

Electronegative low-density lipoprotein is associated with dense low-density lipoprotein in subjects with different levels of cardiovascular risk.

de Queiroz Mello AP, da Silva IT, Oliveira AS, Nunes VS, Abdalla DS, Gidlund M, Damasceno NR. Lipids. 2010 Jul;45(7):619-25.

Effects of margarines and butter consumption on lipid profiles, inflammation markers and lipid transfer to HDL particles in free-living subjects with the metabolic syndrome.

Gagliardi AC, Maranhão RC, Sousa HP, Schaefer EJ, Santos RD. Eur J Clin Nutr. 2010 Oct;64(10):1141-9.

Resident peritoneal inflammatory cells are pivotal in the development of experimental atherosclerosis.

Relvas WG, Izar MC, Segreto HR, Giordani AJ, Ihara SS, Mariano M, Lopes JD, Popi AF, Helfenstein T, Pomaro D, Póvoa RM, Carvalho AC, Fonseca FA. J Atheroscler Thromb. 2010 Apr 30;17(4):378-85.

Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial.

Raal FJ, Santos RD, Blom DJ, Marais AD, Charng MJ, Cromwell WC, Lachmann RH, Gaudet D, Tan JL, Chasan-Taber S, Tribble DL, Flaim JD, Crooke ST. Lancet. 2010 Mar 20;375(9719):998-1006.

Lipid transfer proteins: past, present and perspectives.

Quintão EC, Cazita PM. Atherosclerosis. 2010 Mar;209(1):1-9.

Early increase in autoantibodies against human oxidized low-density lipoprotein in hypertensive patients after blood pressure control.

Brandão SA, Izar MC, Fischer SM, Santos AO, Monteiro CM, Póvoa RM, Helfenstein T, Carvalho AC, Monteiro AM, Ramos E, Gidlund M, Figueiredo Neto AM, Fonseca FA. Am J Hypertens. 2010 Feb;23(2):208-14.

Desenvolvido pela Diretoria de Tecnologia da SBC
Todos os Direitos Reservados © Copyright 2015
Sociedade Brasileira de Cardiologia | Tecnologia@cardiol.br